The following are short summaries of recent CBP NY rulings issued by the agency's National Commodity Specialist Division in New York:
toarticlessource documents
Search Primer
Term list: Separate terms with spaces, not commas or semicolons.
Multi-word term: Place inside quotes to ensure an exact match (e.g. "surrogate value").
Acronyms: Use all capital letters to ensure the search is not looking for that letter sequence instead. (e.g., CIT).
Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +ruling).
Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., ruling -NY).
Simplest form: Use the simplest form of a term (e.g. "russian export control" instead of "russian export controls") or "entity list" instead of "entity listing" or "entity listed").
If a reelected President Donald Trump uses the existing Section 301 tariffs program to hike tariffs on all Chinese goods by at least 60%, that's likely to survive a court challenge, said two law professors who spoke during a Washington International Trade Association webinar on the executive branch's ability to make deals and impose trade restrictions without congressional say-so.
The following are short summaries of recent CBP NY rulings issued by the agency's National Commodity Specialist Division in New York:
Trade Law Daily is providing readers with the top stories from last week, in case you missed them. All articles can be found by searching on the title or by clicking on the hyperlinked reference number.
The following are short summaries of recent CBP NY rulings issued by the agency's National Commodity Specialist Division in New York:
The U.S. on Oct. 15 urged the Court of International Trade to dismiss a suit from importer Retractable Technologies challenging the recent 100% increase of Section 301 tariffs on needles and syringes from China. The government said the trade court lacks jurisdiction to "second-guess the President's findings" and discretion in telling the U.S. trade representative to modify the Section 301 action and that the company failed to state a claim on which relief could be provided (Retractable Technologies v. United States, CIT # 24-00185).
Trade Law Daily is providing readers with the top stories from last week, in case you missed them. All articles can be found by searching on the title or by clicking on the hyperlinked reference number.
The following lawsuits were recently filed at the Court of International Trade:
The Court of International Trade on Oct. 9 denied importer Retractable Technologies' motion to quash a prehearing deposition subpoena from the U.S. in the company's suit against the Office of the U.S. Trade Representative's 100% Section 301 rate hike on needles and syringes (Retractable Technologies v. U.S., CIT # 24-00185).
Importer Retractable Technologies on Oct. 8 asked the Court of International Trade to quash the government's motion seeking corporate testimony from the company in Retractable's suit on the Office of the U.S. Trade Representative's 100% Section 301 tariff hike on needles and syringes. Retractable said an upcoming evidentiary hearing before the trade court will give the government the information it seeks and that reasonable time wasn't allowed for the company to respond to the subpoena (Retractable Technologies v. United States, CIT # 24-00185).